Positive and Negative Regulation of TSC2 Activity and Its Effects on Downstream Effectors of the mTOR Pathway

Author： Jozwiak Jaroslaw   Jozwiak Sergiusz   Grzela Tomasz   Lazarczyk Maciej  

Publisher： Humana Press, Inc

ISSN： 1535-1084

Source： NeuroMolecular Medicine, Vol.7, Iss.4, 2005-11, pp. : 287-296

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Tsc2 Null Murine Neuroepithelial Cells Are a Model for Human Tuber Giant Cells, and Show Activation of an mTOR Pathway

By Onda H.   Crino P.B.   Zhang H.   Murphey R.D.   Rastelli L.   Gould Rothberg B.E.   Kwiatkowski D.J.  

Molecular and Cellular Neuroscience, Vol. 21, Iss. 4, 2002-12 ,pp. : 561-574

Academic Press

Access to resources Recommend Favorite

The Proteasome Inhibitor MG-132 Induces AIF Nuclear Translocation Through Down-Regulation of ERK and Akt/mTOR Pathway

By Ko Jun   Choi Chang   Kim Yong   Kwon Chae  

Neurochemical Research, Vol. 36, Iss. 5, 2011-05 ,pp. : 722-731

Springer Publishing Company

Access to resources Recommend Favorite

Effect of Combination Treatment of Rapamycin and Isoflavones on mTOR Pathway in Human Glioblastoma (U87) Cells

By Puli Shilpa   Jain Aditi   Lai James   Bhushan Alok  

Neurochemical Research, Vol. 35, Iss. 7, 2010-07 ,pp. : 986-993

Springer Publishing Company

Access to resources Recommend Favorite

mTOR as a potential treatment target for epilepsy

By Wong Michael  

Future Neurology, Vol. 7, Iss. 5, 2012-09 ,pp. : 537-545

Future Medicine

Access to resources Recommend Favorite

Cutting through the Complexities of mTOR for the Treatment of Stroke

By  

Current Neurovascular Research, Vol. 11, Iss. 2, 2014-05 ,pp. : 177-186

Bentham Science Publishers

Access to resources Recommend Favorite